Literature DB >> 3098911

O-acetylation of peptidoglycan in Neisseria gonorrhoeae. Investigation of lipid-linked intermediates and glycan chains newly incorporated into the cell wall.

A L Lear, H R Perkins.   

Abstract

Radioactive labelling of the amino sugars in gonococcal peptidoglycan was followed by treatment with Chalaropsis muramidase and TLC separation of the products. Even after very brief periods of labelling (0.5 min) the peptidoglycan was already cross-linked to some 80% of the final value and little change occurred within 2 min. The remaining cross-linking was achieved only over a period of about one generation time. Streptomycete endopeptidase was used to show the extent to which new chains were cross-linked to old. Even at the earliest times many cross-linked units contained new material in both moieties and by 3 min there was little distinction in relative labelling, indicating that in Neisseria gonorrhoeae most newly synthesized glycan chains are cross-linked to other new chains rather than to pre-existing peptidoglycan. A model is proposed in which newly polymerized monomer units are predestined either towards dimer formation with other new chains, which are then rapidly O-acetylated and not further cross-linked, or towards the formation of trimers and higher oligomers, the latter being a slower process. Although significant O-acetylation of peptidoglycan was detectable even at the earliest times, efforts to detect O-acetylated lipid intermediates were unsuccessful. The chief lipid intermediate found was apparently the disaccharide-peptide unit linked to undecaprenol.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3098911     DOI: 10.1099/00221287-132-9-2413

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  10 in total

1.  Cross-linkage and cross-linking of peptidoglycan in Escherichia coli: definition, determination, and implications.

Authors:  F Driehuis; B de Jonge; N Nanninga
Journal:  J Bacteriol       Date:  1992-03       Impact factor: 3.490

2.  Structural basis for the O-acetyltransferase function of the extracytoplasmic domain of OatA from Staphylococcus aureus.

Authors:  Carys S Jones; David Sychantha; P Lynne Howell; Anthony J Clarke
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

3.  Evidence for N----O acetyl migration as the mechanism for O acetylation of peptidoglycan in Proteus mirabilis.

Authors:  C Dupont; A J Clarke
Journal:  J Bacteriol       Date:  1991-07       Impact factor: 3.490

4.  Substrate specificity and kinetic characterization of peptidoglycan O-acetyltransferase B from Neisseria gonorrhoeae.

Authors:  Patrick J Moynihan; Anthony J Clarke
Journal:  J Biol Chem       Date:  2014-05-02       Impact factor: 5.157

5.  Changes in composition of peptidoglycan during maturation of the cell wall in pneumococci.

Authors:  H Laitinen; A Tomasz
Journal:  J Bacteriol       Date:  1990-10       Impact factor: 3.490

6.  Production and characterization of a monoclonal antibody to the O-acetylated peptidoglycan of Proteus mirabilis.

Authors:  S Gyorffy; A J Clarke
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

7.  In vitro synthesis and O acetylation of peptidoglycan by permeabilized cells of Proteus mirabilis.

Authors:  C Dupont; A J Clarke
Journal:  J Bacteriol       Date:  1991-08       Impact factor: 3.490

8.  Contribution of gentamicin 2'-N-acetyltransferase to the O acetylation of peptidoglycan in Providencia stuartii.

Authors:  K G Payie; P N Rather; A J Clarke
Journal:  J Bacteriol       Date:  1995-08       Impact factor: 3.490

9.  Mechanism of Staphylococcus aureus peptidoglycan O-acetyltransferase A as an O-acyltransferase.

Authors:  Carys S Jones; Alexander C Anderson; Anthony J Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-07       Impact factor: 11.205

Review 10.  Mechanistic Pathways for Peptidoglycan O-Acetylation and De-O-Acetylation.

Authors:  David Sychantha; Ashley S Brott; Carys S Jones; Anthony J Clarke
Journal:  Front Microbiol       Date:  2018-10-01       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.